🔎 Trials Near Me

홈 › 버킷 림프종 › 테네시

테네시의 버킷 림프종 임상 시험

버킷 림프종 관련 연구 10개가 테네시 내 여러 지역에서 참여자를 모집하고 있습니다.

테네시의 도시

공식 연구 텍스트(영어)

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

  • Research Site, Franklin
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07109219

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • East Tennessee Childrens Hospital, Knoxville
  • The Children's Hospital at TriStar Centennial, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
피험자 모집 중2상
1세 ~ 30세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04546399

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

  • St. Jude Children's Research Hospital, Memphis
피험자 모집 중3상
1세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07223021

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • East Tennessee Childrens Hospital, Knoxville
  • Saint Jude Children's Research Hospital, Memphis
  • The Children's Hospital at TriStar Centennial, Nashville
  • 외 1개
피험자 모집 중2상
365 Days · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • East Tennessee Childrens Hospital, Knoxville
  • The Children's Hospital at TriStar Centennial, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
피험자 모집 중2상
366 Days – 46 Years · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06124157

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • TriStar BMT, Nashville
피험자 모집 중1/2상
13세 ~ 90세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06533579

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • T C Thompson Children's Hospital, Chattanooga
  • East Tennessee Childrens Hospital, Knoxville
  • The Children's Hospital at TriStar Centennial, Nashville
  • 외 1개
피험자 모집 중3상
365 Days – 25 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT03959085

CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia

  • St. Jude Children's Research Hospital, Memphis
피험자 모집 중1상
21세 이하 · 모든 성별 · 2026. 5. 19. 업데이트됨 · NCT06777979

CAR T-cell Long-Term Follow-Up, Quality of Life and Adverse Reactions

  • St. Jude Children's Research Hospital, Memphis
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 4. 29. 업데이트됨 · NCT07048535

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

  • TriStar Bone Marrow Transplant, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2024. 11. 15. 업데이트됨 · NCT06034275

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.